SECOND AMENDED AND RESTATED MANAGEMENT AGREEMENT Dated as of October 3, 2022Management Agreement • November 8th, 2022 • Royalty Pharma PLC • Pharmaceutical preparations • New York
Contract Type FiledNovember 8th, 2022 Company Industry JurisdictionThis SECOND AMENDED AND RESTATED MANAGEMENT AND SERVICES AGREEMENT (this “Agreement”) is effective as of the 3rd day of October, 2022, among ROYALTY PHARMA INVESTMENTS 2019 ICAV having its registered office at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (hereinafter called the “ICAV”), and RP MANAGEMENT, LLC, a Delaware limited liability company (the “Manager”). Capitalized terms used in the preamble and recitals of this Agreement and not otherwise defined therein are defined in Section 1 (Definitions).
AMENDED AND RESTATED MANAGEMENT AGREEMENT Dated as of 11 June, 2020Management Agreement • October 13th, 2020 • Royalty Pharma PLC • Pharmaceutical preparations • New York
Contract Type FiledOctober 13th, 2020 Company Industry JurisdictionThis AMENDED AND RESTATED MANAGEMENT AND SERVICES AGREEMENT (this “Agreement”) is effective as of the 11th day of June, 2020, among ROYALTY PHARMA INVESTMENTS 2019 ICAV having its registered office at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (hereinafter called the “ICAV”), and RP MANAGEMENT, LLC, a Delaware limited liability company (the “Manager”). Capitalized terms used in the preamble and recitals of this Agreement and not otherwise defined therein are defined in Section 1 (Definitions).
AMENDED AND RESTATED MANAGEMENT AGREEMENT Dated as of 11 June, 2020Management Agreement • September 29th, 2020 • Royalty Pharma PLC • Pharmaceutical preparations • New York
Contract Type FiledSeptember 29th, 2020 Company Industry JurisdictionThis AMENDED AND RESTATED MANAGEMENT AND SERVICES AGREEMENT (this “Agreement”) is effective as of the 11th day of June, 2020, among ROYALTY PHARMA INVESTMENTS 2019 ICAV having its registered office at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (hereinafter called the “ICAV”), and RP MANAGEMENT, LLC, a Delaware limited liability company (the “Manager”). Capitalized terms used in the preamble and recitals of this Agreement and not otherwise defined therein are defined in Section 1 (Definitions).
AMENDED AND RESTATED MANAGEMENT AGREEMENT Dated as of 11 June, 2020Management Agreement • June 19th, 2020 • Royalty Pharma PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 19th, 2020 Company Industry JurisdictionThis AMENDED AND RESTATED MANAGEMENT AND SERVICES AGREEMENT (this “Agreement”) is effective as of the 11th day of June, 2020, among ROYALTY PHARMA INVESTMENTS 2019 ICAV having its registered office at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (hereinafter called the “ICAV”), and RP MANAGEMENT, LLC, a Delaware limited liability company (the “Manager”). Capitalized terms used in the preamble and recitals of this Agreement and not otherwise defined therein are defined in Section 1 (Definitions).
AMENDED AND RESTATED MANAGEMENT AGREEMENT Dated as of , 2020Management Agreement • May 22nd, 2020 • Royalty Pharma PLC • Pharmaceutical preparations • New York
Contract Type FiledMay 22nd, 2020 Company Industry JurisdictionThis AMENDED AND RESTATED MANAGEMENT AND SERVICES AGREEMENT (this “Agreement”) is effective as of the day of , 2020, among ROYALTY PHARMA INVESTMENTS 2019 ICAV having its registered office at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (hereinafter called the “ICAV”), and RP MANAGEMENT, LLC, a Delaware limited liability company (the “Manager”). Capitalized terms used in the preamble and recitals of this Agreement and not otherwise defined therein are defined in Section 1 (Definitions).